Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities

Journal of Clinical Microbiology

Volumn 51, Issue 5, 2013, Pages 1458-1464

  Schmitt, Markus ^a   Depuydt, Christophe ^b   Benoy, Ina ^b   Bogers, Johannes ^b   Antoine, Jerome ^c   Arbyn, Marc ^c   Pawlita, Michael ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b Laboratory for clinical pathology (Labo Lokeren Campus Riatol)   (Belgium)

^c SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ARTICLE; BIOASSAY; CANCER CYTODIAGNOSIS; CANCER GRADING; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MIXED INFECTION; NONHUMAN; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SQUAMOUS CELL; TREND STUDY; TUMOR INVASION; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS LOAD; ADOLESCENT; ADULT; AGED; CLASSIFICATION; CYTOLOGY; GENETICS; MIDDLE AGED; PAPILLOMA VIRUS; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; UTERINE CERVIX; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX TUMOR; VIROLOGY; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS;

VIRUS DNA;

ADOLESCENT; ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASMS, SQUAMOUS CELL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TREATMENT OUTCOME; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VIRAL LOAD; YOUNG ADULT;

EID: 84876799241     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00087-13     Document Type: Article

References (34)

1. Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, de Villiers EM. 2010. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401:70-79.
2. Antonsson A, Forslund O, Ekberg H, Sterner G, Hansson BG. 2000. The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J. Virol. 74:11636-11641.
3. IARC. 2012. Agents classified by the IARC monographs, vol. 1-100. International Agency for Research on Cancer. http://monographs.iarc.fr /ENG/Classification/index.php.
4. Schiffman M, Clifford G, Buonaguro FM. 2009. Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect. Agent. Cancer 4:8.
5. Calleja-Macias IE, Kalantari M, Allan B, Williamson AL, Chung LP, Collins RJ, Zuna RE, Dunn ST, Ortiz-Lopez R, Barrera-Saldaña HA, Cubie HA, Cuschieri K, Villa LL, Bernard HU. 2005. Papillomavirus subtypes are natural and old taxa: phylogeny of human papillomavirus types 44 and 55 and 68a and-b. J. Virol. 79:6565-6569.
6. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:12-19.
7. IARC. 2007. IARC monographs on the evaluation of carcinogenic risks to humans, vol 90. International Agency for Research on Cancer. http: //monographs.iarc.fr/ENG/Monographs/vol90/index.php.
8. Schiffman M, Kjaer SK. 2003. Chapter 2: natural history of anogenital human papillomavirus infection and neoplasia. J. Natl. Cancer Inst. Monogr. 2003:14-19.
9. Wentzensen N, Schiffman M, Dunn T, Zuna RE, Gold MA, Allen RA, Zhang R, Sherman ME, Wacholder S, Walker J, Wang SS. 2009. Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int. J. Cancer 125:2151-2158.
10. Schmitt M, Dondog B, Waterboer T, Pawlita M, Tommasino M, Gheit T. 2010. Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay. J. Clin. Microbiol. 48:143-149.
11. Sherman ME, Wang SS, Wheeler CM, Rich L, Gravitt PE, Tarone R, Schiffman M. 2003. Determinants of human papillomavirus load among women with histological cervical intraepithelial neoplasia 3: dominant impact of surrounding low-grade lesions. Cancer Epidemiol. Biomarkers Prev. 12:1038-1044.
12. Arbyn M, Schneider A, Gissmann L, Kaufmann A. 2012. Highlights of the 27th International Papillomavirus Conference and clinical workshop: part 2: applied clinical science. Future Virol. 7:127-133.
13. Schmitt M, Depuydt C, Benoy I, Bogers J, Antoine J, Arbyn M, Pawlita M, on behalf of the VALGENT Study Group. 2012. Prevalence and viral load of 51 genital human papillomavirus types and three subtypes. Int. J. Cancer [Epub ahead of print.]
14. Schmitt M, Depuydt CE, Benoy I, Bogers J, Antoine J, Pawlita M, Arbyn M, on behalf of the VALGENT Study Group. 2013. Viral load of high-risk human papillomaviruses as reliable clinical predictor for the presence of cervical lesions. Cancer Epidemiol. Biomarkers Prev. [Epub ahead of print.]
15. Arbyn M, Herbert A, Schenck U, Nieminen P, Jordan J, Mcgoogan E, Patnick J, Bergeron C, Baldauf JJ, Klinkhamer P, Bulten J, Martin-Hirsch P. 2007. European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid-based cytology. Cytopathology 18:133-139.
16. Depuydt CE, Benoy IH, Bailleul EJ, Vandepitte J, Vereecken AJ, Bogers JJ. 2006. Improved endocervical sampling and HPV viral load detection by Cervex-Brush Combi. Cytopathology 17:374-381.
17. Vassilakos P, Griffin S, Megevand E, Campana A. 1998. CytoRich liquid-based cervical cytologic test. Screening results in a routine cytopathology service. Acta Cytol. 42:198-202.
18. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T, Jr, Young N, Forum Group Members, Bethesda 2001 Workshop. 2002. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 287:2114-2119.
19. Arbyn M, Van Oyen H. 2000. Cervical cancer screening in Belgium. Eur. J. Cancer 36:2191-2197.
20. Depuydt CE, Vereecken AJ, Salembier GM, Vanbrabant AS, Boels LA, van Herck E, Arbyn M, Segers K, Bogers JJ. 2003. Thin-layer liquidbased cervical cytology and PCR for detecting and typing human papillomavirus DNA in Flemish women. Br. J. Cancer 88:560-566.
21. Schmitt M, Dondog B, Waterboer T, Pawlita M. 2008. Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5-and GP6-primers. J. Clin. Microbiol. 46: 1050-1059.
22. Schmitt M, Bravo IG, Snijders PJ, Gissmann L, Pawlita M, Waterboer T. 2006. Bead-based multiplex genotyping of human papillomaviruses. J. Clin. Microbiol. 44:504-512.
23. Bosch FX, Muñoz N. 2002. The viral etiology of cervical cancer. Virus Res. 89:183-190.
24. Han J, Swan DC, Smith SJ, Lum SH, Sefers SE, Unger ER, Tang YW. 2006. Simultaneous amplification and identification of 25 human papillomavirus types with Templex technology. J. Clin. Microbiol. 44:4157-4162.
25. Mendez F, Munoz N, Posso H, Molano M, Moreno V, van den Brule AJ, Ronderos M, Meijer C, Munoz A, Instituto Nacional de Cancerologia Human Papillomavirus Study Group. 2005. Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines. J. Infect. Dis. 192:1158-1165.
26. Cuschieri KS, Cubie HA, Whitley MW, Seagar AL, Arends MJ, Moore C, Gilkisson G, McGoogan E. 2004. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J. Clin. Pathol. 57:68-72.
27. Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J, Balmaceda I, Greenberg MD, Alfaro M, Burk RD, Wacholder S, Plummer M, Schiffman M. 2000. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J. Natl. Cancer Inst. 92:464-474.
28. Levi JE, Kleter B, Quint WG, Fink MC, Canto CL, Matsubara R, Linhares I, Segurado A, Vanderborght B, Neto JE, van Doorn LJ. 2002. High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virusinfected women in Brazil. J. Clin. Microbiol. 40:3341-3345.
29. Carozzi F, Ronco G, Gillio-Tos A, De Marco L, Del Mistro A, Girlando S, Franceschi S, Plummer M, Vaccarella S, New Technologies for Cervical Cancer Screening (NTCC) Working Group. 2012. Concurrent infections with multiple human papillomavirus (HPV) types in the New Technologies for Cervical Cancer (NTCC) screening study. Eur. J. Cancer 48:1633-1637.
30. Chaturvedi AK, Katki HA, Hildesheim A, Rodriguez AC, Quint W, Schiffman M, Van Doorn LJ, Porras C, Wacholder S, Gonzalez P, Sherman ME, Herrero R, CVT Group. 2011. Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease. J. Infect. Dis. 203:910-920.
31. Rositch AF, Poole C, Hudgens MG, Agot K, Nyagaya E, Moses S, Snijders PJ, Meijer CJ, Bailey RC, Smith JS. 2012. Multiple human papillomavirus infections and type competition in men. J. Infect. Dis. 205:72-81.
32. Vaccarella S, Franceschi S, Herrero R, Schiffman M, Rodriguez AC, Hildesheim A, Burk RD, Plummer M. 2011. Clustering of multiple human papillomavirus infections in women from a population-based study in Guanacaste, Costa Rica. J. Infect. Dis. 204:385-390.
33. Vaccarella S, Plummer M, Franceschi S, Gravitt P, Papenfuss M, Smith D, Villa L, Ponce EL, Giuliano AR. 2011. Clustering of human papillomavirus (HPV) types in the male genital tract: the HPV in men (HIM) study. J. Infect. Dis. 204:1500-1504.
34. Quint W, Jenkins D, Molijn A, Struijk L, van de Sandt M, Doorbar J, Mols J, Van Hoof C, Hardt K, Struyf F, Colau B. 2012. One virus, one lesion-individual components of CIN lesions contain a specific HPV type. J. Pathol. 227:62-71.